SHEETAL KHEDKAR, Deputy Therapeutic Area Safety Head, Janssen Pharmaceutical

Medical professional with over 15 years of industry, CRO and academia experience in phase I-IV oncology and rare diseases clinical research. Held multiple strategic leadership positions as AVP, Global Pharmacovigilance & Regulatory Science at Sarah Cannon, and currently Deputy Therapeutic Area Safety Head, Hematologic Malignancies at Janssen R&D, Johnson & Johnson